Predicting IVF outcome in poor ovarian responders.
Bologna criteria
In vitro fertilization
Live birth
Poor ovarian response
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
30 09 2022
30 09 2022
Historique:
received:
07
06
2022
accepted:
29
08
2022
entrez:
30
9
2022
pubmed:
1
10
2022
medline:
5
10
2022
Statut:
epublish
Résumé
Poor responders to ovarian stimulation are one of the most challenging populations to treat. As a failed cycle can cause a considerable emotional and economical loss, adequate fertility counseling addressing patients' expectations are highly important when facing patients with poor ovarian response. The study aimed to evaluate reproductive outcomes and to identify factors associated with live birth (LB) after fresh autologous IVF/intracytoplasmic sperm injection (ICSI) cycles of patients fulfilling the Bologna criteria for poor ovarian response (POR). A retrospective study included 751 IVF/ICSI treatment cycles which yielded up to three retrieved oocytes, at a tertiary referral hospital between January 2016 and February 2020. A logistic regression analysis was used to adjust for confounders. Clinical pregnancy and LB rate per cycle were significantly higher among women younger versus older than 40 years (9.8% and 6.8% vs 4.5% and 2.1%, p < 0.01, respectively). Patients who achieved LB were significantly younger, had higher number of oocytes retrieved, fertilization rate and top-quality embryos (p < 0.05). Multivariable regression analysis identified patient's age (OR 0.90; 95% CI 0.845-0.97; p = 0.005) and mean number retrieved oocytes (OR 1.95; 95% CI 1.20-3.16; p = 0.007) as factors significantly associated with the probability of a LB. The woman's age and the number of retrieved oocytes are both independent predicting factors of live birth in poor ovarian responders. Considering the risks, the high financial investment and poor reproductive outcomes involved in IVF treatments, raises questions regarding the adequacy of providing treatments in these patients' population. POR younger than 40 years may represent a possible exception due to acceptable probability for a LB.
Sections du résumé
BACKGROUND
Poor responders to ovarian stimulation are one of the most challenging populations to treat. As a failed cycle can cause a considerable emotional and economical loss, adequate fertility counseling addressing patients' expectations are highly important when facing patients with poor ovarian response. The study aimed to evaluate reproductive outcomes and to identify factors associated with live birth (LB) after fresh autologous IVF/intracytoplasmic sperm injection (ICSI) cycles of patients fulfilling the Bologna criteria for poor ovarian response (POR).
METHODS
A retrospective study included 751 IVF/ICSI treatment cycles which yielded up to three retrieved oocytes, at a tertiary referral hospital between January 2016 and February 2020. A logistic regression analysis was used to adjust for confounders.
RESULTS
Clinical pregnancy and LB rate per cycle were significantly higher among women younger versus older than 40 years (9.8% and 6.8% vs 4.5% and 2.1%, p < 0.01, respectively). Patients who achieved LB were significantly younger, had higher number of oocytes retrieved, fertilization rate and top-quality embryos (p < 0.05). Multivariable regression analysis identified patient's age (OR 0.90; 95% CI 0.845-0.97; p = 0.005) and mean number retrieved oocytes (OR 1.95; 95% CI 1.20-3.16; p = 0.007) as factors significantly associated with the probability of a LB.
CONCLUSIONS
The woman's age and the number of retrieved oocytes are both independent predicting factors of live birth in poor ovarian responders. Considering the risks, the high financial investment and poor reproductive outcomes involved in IVF treatments, raises questions regarding the adequacy of providing treatments in these patients' population. POR younger than 40 years may represent a possible exception due to acceptable probability for a LB.
Identifiants
pubmed: 36180882
doi: 10.1186/s12905-022-01964-y
pii: 10.1186/s12905-022-01964-y
pmc: PMC9524122
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
395Informations de copyright
© 2022. The Author(s).
Références
Biol Reprod. 2004 Feb;70(2):419-24
pubmed: 14561658
Hum Reprod. 2011 Jul;26(7):1616-24
pubmed: 21505041
Reprod Sci. 2016 Aug;23(8):1103-8
pubmed: 26902430
Reprod Biomed Online. 2014 Apr;28(4):469-74
pubmed: 24581984
J Assist Reprod Genet. 1998 Aug;15(7):431-7
pubmed: 9717119
PLoS One. 2012;7(10):e46544
pubmed: 23056338
J Assist Reprod Genet. 2004 Mar;21(3):79-83
pubmed: 15202735
Front Endocrinol (Lausanne). 2018 Jun 29;9:327
pubmed: 30008696
Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):553-558
pubmed: 33784935
Fertil Steril. 2005 Feb;83(2):331-5
pubmed: 15705370
Gynecol Obstet Invest. 2020;85(4):357-361
pubmed: 32580194
Hum Reprod. 2005 Mar;20(3):622-8
pubmed: 15608035
Hum Reprod. 2018 Aug 1;33(8):1489-1498
pubmed: 30010882
Hum Reprod Update. 2013 Jan-Feb;19(1):26-36
pubmed: 23188168
Fertil Steril. 2011 Nov;96(5):1058-61.e7
pubmed: 22036048
Fertil Steril. 2004 May;81(5):1247-53
pubmed: 15136085
Br J Obstet Gynaecol. 1997 May;104(5):521-7
pubmed: 9166190
J Ovarian Res. 2015 Aug 21;8:60
pubmed: 26293447
Hum Reprod. 1997 Feb;12(2):241-3
pubmed: 9070703
Biomed Res Int. 2014;2014:352098
pubmed: 25136579
Hum Reprod. 2007 Sep;22(9):2404-13
pubmed: 17640944
J Assist Reprod Genet. 2000 Aug;17(7):357-73
pubmed: 11077616
Hum Reprod. 2000 Nov;15(11):2341-6
pubmed: 11056129
Gynecol Endocrinol. 1994 Dec;8(4):277-86
pubmed: 7709768
Endocr Rev. 2006 Apr;27(2):170-207
pubmed: 16434510
Hum Reprod Update. 2010 Nov-Dec;16(6):577-89
pubmed: 20581128
Hum Reprod Update. 2012 Jan-Feb;18(1):1-11
pubmed: 21987525
Hum Reprod. 2011 Jul;26(7):1768-74
pubmed: 21558332
Fertil Steril. 1998 Jun;69(6):1001-4
pubmed: 9627283
Endocr Rev. 2009 Aug;30(5):465-93
pubmed: 19589949
Fertil Steril. 2014 Aug;102(2):394-8
pubmed: 24890269
Lancet. 1991 Jun 8;337(8754):1375-7
pubmed: 1674764
Hum Reprod. 2017 Jul 1;32(7):1439-1449
pubmed: 28472455